PRIMAEGIS RESEARCH · INVESTMENT ANALYSIS PIPELINE
₹517
+5.00% · Mkt Cap ₹10,622 Cr
52W: ₹183 – ₹517

E2E Networks

NSE: E2E · NSE-listed (BSE 544783) · AI Cloud / GPU Infrastructure · Report date: 2026-07-25
Q1 FY27: revenue +334% YoYExit MRR ₹71.8 Cr (Mar: ₹37.4)Trailing ROCE −0.5%Promoter −20.3% over 3YP/E 341 (ttm) · 6.3× bookAt 52-week high
Market Cap
₹10,622 Cr
CMP
₹517
ROCE (ttm)
−0.5%
ROE (ttm)
−0.9%
P/E (ttm)
341
Revenue TTM
₹366 Cr
PAT TTM
₹31 Cr
Q1 FY27 PAT
₹44 Cr
D/E
0.09
OPM Q1
75%
A1 · Business Model & Moat
screener.in · company disclosures

NSE-listed AI-focused hyperscale cloud: cloud GPUs (H100/H200/A100, and from Jan-2026 a 1,024-unit Nvidia B200 cluster in Chennai), the TIR AI/ML platform, AI-labs-as-a-service and a Sovereign Cloud offering. The model: buy accelerators, rent them by the GPU-hour with INR billing and data-residency — India's sovereign-AI first mover among listed names.

Moat assessment

  • Efficient scale — moderate: ~5,100 GPUs deployed; first-wave access to Nvidia supply in India.
  • Switching costs — developing: TIR platform + data gravity once training pipelines are resident.
  • None on price: hyperscalers (AWS/Azure) and new entrants can compress GPU-hour pricing at will.

Model economics

  • Capex-first: FY26 FCF −₹1,140 Cr; depreciation ₹169 Cr swamped FY26 P&L (net −₹16 Cr).
  • Operating leverage is violent in both directions: Q1 FY27 OPM 75% once utilisation caught up.
  • Nearly debt-free (D/E 0.09) — the ₹1,593 Cr FY25 raise funds the build.
A3 · Opportunity & Recent Developments
cited news

TAM: India sovereign-AI + GenAI compute demand, with INR billing and residency as the wedge against hyperscalers. The bet is utilisation staying ahead of the depreciation wave each new cluster brings.

A5 · Financials — 5-Year Trend
screener.in annual P&L
FYSales ₹CrYoYPAT ₹CrOPM
FY2252644%
FY2366+26.9%1050%
FY2494+42.4%2251%
FY25164+74.5%4759%
FY26246+50.0%-1651%
Read FY26's loss correctly: operating profit ₹126 Cr was positive and growing — ₹169 Cr of new-fleet depreciation drove the net loss. TTM: sales ₹366 Cr, PAT ₹31 Cr. The Jun-2026 quarter alone did ₹157 Cr / ₹44 Cr.
A8 · Balance Sheet & Fraud Filter
screener.in · FY26
ItemFY26 ₹CrFY25 ₹Cr
Equity + Reserves1,6851,593
Borrowings15973
Fixed Assets1,036389
CWIP533636
Total Assets2,3282,581

Fraud filter

CFO quality — CFO positive every year of the build (₹122 Cr FY26); losses were depreciation, not cash
🔴Promoter holding — down 20.3% over three years into a rising price
Leverage — D/E 0.09 — the build is equity-funded
⚠️FCF — −₹1,140 Cr FY26 — deliberate, but leaves no room for a demand air-pocket
Receivables — 25 debtor days — customers pay like a utility
A9 · Quarterly Cadence
screener.in · last 6 quarters
QuarterSales ₹CrYoYOP ₹CrOPMPAT ₹Cr
Mar-2533+13.8%1340%14
Jun-2536-12.2%1129%-3
Sep-2544-8.3%1841%-13
Dec-2570+66.7%4057%-6
Mar-2696+190.9%5861%6
Jun-26157+336.1%11875%44
Three loss quarters as each GPU tranche landed its depreciation before its revenue — then the crossover. Jun-2026 is the first quarter of the new economics.
A10 · Valuation
screener.in ratios
MetricCurrentContext
P/E (ttm)341meaningless on trailing losses rolling off
P/E (Q1 annualised)~61on ₹8.5 EPS run-rate — the honest bull framing
P/B6.3×book ₹82
EV/Sales (ttm)~28×vs global GPU-cloud comps (CoreWeave et al.) at high-single to low-double digits
Everything depends on MRR compounding: at ₹71.8 Cr exit MRR the forward revenue base is ~₹860 Cr annualised — the multiple is paying for that to keep doubling.
A13 · Risks
sorted by severity
HIGH

Returns on capital still negative (ttm)

ROCE −0.5%: the fleet has to sweat for years to earn its cost; every new cluster resets the clock.
Mitigant: watch utilisation/MRR each quarter
HIGH

Promoter selling

−20.3% over three years into strength — whatever the reason, the insider with the most information reduced.
Mitigant: monitor further SAST disclosures
HIGH

Price competition

hyperscalers and funded entrants can cut GPU-hour pricing; H100-class rates fell globally through 2025-26.
Mitigant: INR billing/sovereign wedge is the partial hedge
MEDIUM

Technology obsolescence

B200 today, next architecture in 18 months — depreciation cycles compress.
Mitigant: Nvidia partnership cadence
MEDIUM

Customer concentration

large AI training deals are lumpy; MRR quality not disclosed by client.
Mitigant: seek disclosure in concalls
LOW

Balance sheet

D/E 0.09 and CFO positive — the funding risk is dilution, not debt.
Mitigant: —
A14 · Milestones to Watch
research tracking signals — not investment signals
A15 · Ownership
screener.in analysis flags
Shareholding table unavailable from the source this run. Known from screener analysis flags: promoter holding decreased 20.3% over the last three years. L&T holds a strategic stake (via the 2024-25 investment). Refresh next run.
Part B · Technical Posture
All technical levels are Research Reference Levels from the 25-Jul weekly pipeline (TradingView scanner data) — not buy/sell signals. Regime this week: Pullback in Bear, Swing Confidence 0/3 — every setup is WATCH-ONLY by rule.
Stage
Stage 2
S2 Score
5 / 5
RS vs CNX500
97th pct
TV Weekly TA
STRONG BUY
📈 Live Chart
TradingView Desktop MCP unavailable at report generation time.
View live chart: NSE:E2E on TradingView ↗️
⚡ CONSOLIDATED VIEW THESIS
Research Reference Only — Not an Investment Recommendation · Primaegis Research Pipeline

💡 INVESTMENT CASE SUMMARY

E2E is the listed pure-play on Indian sovereign AI compute, and July 2026 is its inflection: after a year in which ₹169 Cr of new-fleet depreciation produced paper losses, the June quarter printed ₹157 Cr revenue, 75% OPM and ₹44 Cr PAT, with exit MRR nearly doubling in three months. The chart closed at a 52-week high on 97th-percentile relative strength. The price — 341× trailing, ~61× the Q1 run-rate, 6.3× book — pays in advance for that inflection to compound, from a company whose promoters have sold a fifth of their stake into the rise.

📊 FUNDAMENTAL PILLARS

MRR inflection
exit MRR ₹37.4 Cr → ₹71.8 Cr in one quarter; Q1 revenue +334% YoY. Source: A3/A9
Cash-generative build
CFO positive every year of the capex wave; losses were depreciation timing. Source: A8
Strategic moats forming
B200 first-mover, L&T partnership, sovereign/INR wedge. Source: A1/A3

📈 TECHNICAL POSTURE

52-week-high breakout
closed at the high with 97th-pct RS — the tape's purest momentum expression this week
Extended
RSI 75, nearing the 78 harvest line; first shelf/pullback is the study
Gate shut
watch-only under the regime; momentum names get half-slots when the gate opens
Fundamentals vs Technicals
MIXED
Technicals scream leadership; trailing fundamentals are still negative-return — conviction rests entirely on the Q1 inflection persisting.

⚠️ PRIMARY RISKS TO THESIS

MRR stalls
one flat MRR quarter and both the E and the multiple compress together
Promoter selling continues
further reduction into strength would be disqualifying for the thesis
GPU price war
hyperscaler pricing pressure compresses the GPU-hour economics the model rents out

🎯 RESEARCH WATCHLIST VERDICT

MONITOR
🔑 Catalyst: Q2 FY27 MRR/PAT print — confirm the level-shift
⏱ Horizon: Near-term (0–3M)
Research tracking priority only — not a buy/sell/hold recommendation per SEBI (RA) Regulations 2014
Primaegis Research Opinion · Internal Analyst View
SPECULATIVE
📊 Conviction: Low  ·  ⏱ Horizon: Near-term (0–3M)
🔄 Would change if: two consecutive quarters of MRR growth + promoter stake stabilising would upgrade; a flat MRR quarter would remove it
STRONG BUYBUYACCUMULATENEUTRAL (HOLD)REDUCESELLSTRONG SELL
⚠️ This is an internal, unregulated analytical opinion of Primaegis Research for internal pipeline use only. It does NOT constitute a SEBI-regulated investment recommendation, research report, or solicitation to buy, sell, or hold any security. Consult a SEBI-registered investment advisor before making any financial decision.
⚠️ IMPORTANT DISCLAIMER
This document is a research and educational output only, generated by the Primaegis Research Investment Analysis Pipeline. Neither Ameya Pimpalgaonkar nor any contributor to this report is a SEBI registered investment advisor or research analyst. Nothing in this report constitutes investment advice, a research recommendation, or a solicitation to buy, sell, or hold any security, fund, or financial instrument under SEBI (Research Analyst) Regulations, 2014 or any other applicable law. All financial data is sourced from publicly available disclosures (screener.in, NSE/BSE filings, company releases). All technical levels are reference levels for research tracking only. Always conduct your own due diligence and consult a SEBI registered investment advisor before making any financial decision.
Generated: 2026-07-25 | Primaegis Research · Not for distribution.